Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 16;100(28):e26571. doi: 10.1097/MD.0000000000026571

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0

PMC Copyright notice

(A) Course of HBsAg during follow-up in both antiviral treatment groups. Data are presented as mean (two-tailed Student's t-test) and plotted in Log2 scale. (B) Course of HDV RNA during follow-up in both antiviral treatment groups. Data are presented as mean (F-test) and plotted in Log2 scale. (C) Loss of HBsAg during follow-up according the 3 treatment groups. Undetectability of HBsAg could not show statistical significance, mostly due to the small number of cases. (D) HDV undetectability according the 3 treatment groups along follow-up. There was no significant difference in the achievement of HDV-RNA loss observed. Statistical significance, ^∗P < .05; ^∗∗P < .001; ^∗∗∗P < .001; ^∗∗∗∗P < .0001. ^†, loss of HBsAg at last observation; ‡, loss of HDV RNA at last observation. IFNα = interferon alpha, NA = nucleos(t)ide analogues.